Study shows game-changing obesity drug more than halves risk of type 2 diabetes
The risk of type 2 diabetes (T2D) is more than halved by weekly injections of new obesity drug semaglutide, according to new research being presented at the annual meeting of the European Association for the Study of Diabetes ...
Sep 12, 2022
0
14